Hematologic Malignancies and Clinical Trial Participation: A Shared Decision-Making Approach

Hematologic Malignancies and Clinical Trial Participation: A Shared Decision-Making Approach

 Hematology

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other members of the care team will receive a certificate of participation.

  • Listing ID: 2991